{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:57:04Z","timestamp":1787644624780,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Autonomous Region Science and Technology Department Support Program of Xinjiang Province","award":["No. 2022E02132"],"award-info":[{"award-number":["No. 2022E02132"]}]},{"name":"Autonomous Region Science and Technology Department Support Program of Xinjiang Province","award":["No. 2022E02132"],"award-info":[{"award-number":["No. 2022E02132"]}]},{"name":"Autonomous Region Science and Technology Department Support Program of Xinjiang Province","award":["No. 2022E02132"],"award-info":[{"award-number":["No. 2022E02132"]}]},{"name":"Autonomous Region Science and Technology Department Support Program of Xinjiang Province","award":["No. 2022E02132"],"award-info":[{"award-number":["No. 2022E02132"]}]},{"name":"Autonomous Region Science and Technology Department Support Program of Xinjiang Province","award":["No. 2022E02132"],"award-info":[{"award-number":["No. 2022E02132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-025-06315-z","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:04:21Z","timestamp":1742375061000},"page":"2189-2206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review"],"prefix":"10.1007","volume":"104","author":[{"given":"Muyassar","family":"Yusup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuangSheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuTing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluopaer","family":"Tuerxun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianPing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"6315_CR1","doi-asserted-by":"publisher","unstructured":"J M R TPure Red Cell Aplasia[J]. Blood, (2016): 2504\u20132509. https:\/\/doi.org\/10.1182\/blood-2016-05-717140.","DOI":"10.1182\/blood-2016-05-717140"},{"issue":"3","key":"6315_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.amjms.2023.06.009","volume":"366","author":"R Means","year":"2023","unstructured":"Means R, TPure Red Cell Aplasia (2023) The second hundred Years [J\/OL]. Am J Med Sci 366(3):160\u2013166. https:\/\/doi.org\/10.1016\/j.amjms.2023.06.009","journal-title":"Am J Med Sci"},{"issue":"1","key":"6315_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2141.1991.tb04392.x","volume":"78","author":"RTJ Means","year":"1991","unstructured":"Means RTJ, Dessypris EN, Krantz S (1991) BTreatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical Response.[J]. Br J Haematol 78(1):114\u2013119. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb04392.x","journal-title":"Br J Haematol"},{"issue":"2","key":"6315_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2141.1981.tb08455.x","volume":"48","author":"EN Dessypris","year":"1981","unstructured":"Dessypris EN, McKee CLJ, Metzantonakis C et al (1981) Red cell aplasia and chronic granulocytic Leukaemia.[J]. Br J Haematol 48(2):217\u2013225. https:\/\/doi.org\/10.1111\/j.1365-2141.1981.tb08455.x","journal-title":"Br J Haematol"},{"issue":"3","key":"6315_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1053\/j.seminhematol.2022.07.001","volume":"59","author":"T Kawakami","year":"2022","unstructured":"Kawakami T, Nakazawa H (2022) Ishida fsomatic mutations in acquired pure red cell Aplasia.[J]. Semin Hematol 59(3):131\u2013136. https:\/\/doi.org\/10.1053\/j.seminhematol.2022.07.001","journal-title":"Semin Hematol"},{"issue":"15","key":"6315_CR6","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood.2021010898","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari C, Maciejewski J (2021) PHow I manage acquired pure red cell aplasia in Adults.[J]. Blood 137(15):2001\u20132009. https:\/\/doi.org\/10.1182\/blood.2021010898","journal-title":"Blood"},{"key":"6315_CR7","unstructured":"Means RT, JUpdate on Pure Red Cell Aplasia: Etiology, Diagnosis, and Treatment.[Z](2022\u201301)"},{"key":"6315_CR8","unstructured":"Kawakami T, Sekiguchi N, Otsuka T et al (2017) Recurrent STAT3 mutations in the lymphocytes of pure red cell aplasia without T-Cell large granular lymphocytic Leukemia[J\/OL]. Blood, 130"},{"issue":"2","key":"6315_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood.V63.2.277.277","volume":"63","author":"DA Clark","year":"1984","unstructured":"Clark DA, Dessypris EN, Krantz S (1984) BStudies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 Patients.[J]. Blood 63(2):277\u2013286","journal-title":"Blood"},{"issue":"3","key":"6315_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s002770050151","volume":"72","author":"YL Kwong","year":"1996","unstructured":"Kwong YL, Wong KF, Liang RH et al (1996) Pure red cell Aplasia: clinical features and treatment results in 16 Cases.[J]. Ann Hematol 72(3):137\u2013140. https:\/\/doi.org\/10.1007\/s002770050151","journal-title":"Ann Hematol"},{"issue":"7","key":"6315_CR11","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","volume":"87","author":"MQ Lacy","year":"1996","unstructured":"Lacy MQ, Kurtin PJ (1996) Tefferi apure red cell Aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic Abnormalities.[J]. Blood 87(7):3000\u20133006","journal-title":"Blood"},{"issue":"11","key":"6315_CR12","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831","volume":"87","author":"RJ Charles","year":"1996","unstructured":"Charles RJ, Sabo KM, Kidd PG et al (1996) The pathophysiology of pure red cell Aplasia: implications for Therapy.[J]. Blood 87(11):4831\u20134838","journal-title":"Blood"},{"issue":"3","key":"6315_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","volume":"135","author":"CA Thompson","year":"2006","unstructured":"Thompson CA, Steensma D (2006) PPure red cell aplasia associated with thymoma: clinical insights from a 50-Year Single-Institution Experience.[J]. Br J Haematol 135(3):405\u2013407. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06295.x","journal-title":"Br J Haematol"},{"issue":"8","key":"6315_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N et al (2007) Long-Term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA collaborative study Group.[J]. Haematologica 92(8):1021\u20131028. https:\/\/doi.org\/10.3324\/haematol.11192","journal-title":"Haematologica"},{"issue":"10","key":"6315_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.12871","volume":"93","author":"N Fujishima","year":"2008","unstructured":"Fujishima N, Sawada K, Hirokawa M et al (2008) Long-Term responses and outcomes following immunosuppressive therapy in large granular lymphocyte Leukemia-Associated pure red cell Aplasia: A nationwide cohort study in Japan for the PRCA collaborative study Group.[J]. Haematologica 93(10):1555\u20131559. https:\/\/doi.org\/10.3324\/haematol.12871","journal-title":"Haematologica"},{"issue":"1","key":"6315_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3324\/haematol.11655","volume":"93","author":"M Hirokawa","year":"2007","unstructured":"Hirokawa M, Sawada K, Fujishima N et al (2007) Long-Term response and outcome following Immuno-Suppressive therapy in Thymoma-Associated pure red cell Aplasia: A nationwide cohort study in Japan by the PRCA collaborative study Group[J]. Haematologica 93(1):27\u201333. https:\/\/doi.org\/10.3324\/haematol.11655","journal-title":"Haematologica"},{"issue":"2","key":"6315_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1179\/102453308X315979","volume":"13","author":"P Malhotra","year":"2008","unstructured":"Malhotra P, Muralikrishna GK, Varma N et al (2008) Spectrum of pure red cell aplasia in adult population of North-West India.[J]. Hematol (Amsterdam Netherlands) 13(2):88\u201391. https:\/\/doi.org\/10.1179\/102453308X315979","journal-title":"Hematol (Amsterdam Netherlands)"},{"issue":"18","key":"6315_CR18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2169\/internalmedicine.52.8291","volume":"52","author":"N Kawano","year":"2013","unstructured":"Kawano N, Nagahiro Y, Yoshida S et al (2013) Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-Year Period.[J]. Intern Med (Tokyo Japan) 52(18):2025\u20132030. https:\/\/doi.org\/10.2169\/internalmedicine.52.8291","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"3","key":"6315_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jtho.2015.11.012","volume":"11","author":"C Rivoisy","year":"2016","unstructured":"Rivoisy C, Besse B, Girard N et al (2016) Thymic epithelial Tumor-Associated cytopenia: A 10-Year observational study in France.[J]. J Thorac Oncology: Official Publication Int Association Study Lung Cancer 11(3):391\u2013399. https:\/\/doi.org\/10.1016\/j.jtho.2015.11.012","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"key":"6315_CR20","doi-asserted-by":"publisher","unstructured":"Peng G, Yang W, Zhang L et al (2016) Hematol (Amsterdam Netherlands) 21(3):138\u2013143. https:\/\/doi.org\/10.1080\/10245332.2015.1101977. Moderate-Dose Cyclophosphamide in the Treatment of Relapsed\/Refractory T-Cell Large Granular Lymphocytic Leukemia-Associated Pure Red Cell Aplasia.[J]","DOI":"10.1080\/10245332.2015.1101977"},{"issue":"11","key":"6315_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/qjmed\/hcx102","volume":"110","author":"E Chalayer","year":"2017","unstructured":"Chalayer E, Costedoat-Chalumeau N, Beyne-Rauzy O et al (2017) Bone marrow involvement in systemic lupus Erythematosus.[J]. QJM. Monthly J Association Physicians 110(11):701\u2013711. https:\/\/doi.org\/10.1093\/qjmed\/hcx102","journal-title":"Monthly J Association Physicians"},{"key":"6315_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.humpath.2017.12.014","volume":"73","author":"M Shi","year":"2018","unstructured":"Shi M, He R, Feldman AL et al (2018) STAT3 mutation and its clinical and histopathologic correlation in T-Cell large granular lymphocytic Leukemia.[J]. Hum Pathol 73:74\u201381. https:\/\/doi.org\/10.1016\/j.humpath.2017.12.014","journal-title":"Hum Pathol"},{"key":"6315_CR23","doi-asserted-by":"publisher","unstructured":"Balasubramanian SK, Sadaps M, Thota S et al (2018) Haematologica 103(2):221\u2013230. https:\/\/doi.org\/10.3324\/haematol.2017.175810. Rational Management Approach to Pure Red Cell Aplasia.[J]","DOI":"10.3324\/haematol.2017.175810"},{"issue":"9","key":"6315_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/10245332.2018.1470068","volume":"23","author":"R Fu","year":"2018","unstructured":"Fu R, Zhang T, Liu B, Hematology, Amsterdam et al (2018) Netherlands) 23(9):639\u2013645. https:\/\/doi.org\/10.1080\/10245332.2018.1470068","journal-title":"Netherlands)"},{"key":"6315_CR25","doi-asserted-by":"publisher","unstructured":"Fujishima N, Hirokawa M, Sawada K et al (2018) Overall survival in acquired pure red cell aplasia in adults following immunosuppressive therapy: preliminary results from the nationwide cohort study (PRCA2016)[J\/OL]. Blood 132. https:\/\/doi.org\/10.1182\/blood-2018-99-114245","DOI":"10.1182\/blood-2018-99-114245"},{"issue":"20","key":"6315_CR26","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","volume":"2","author":"T Kawakami","year":"2018","unstructured":"Kawakami T, Sekiguchi N, Kobayashi J et al (2018) Frequent STAT3 mutations in CD8(+) T cells from patients with pure red cell Aplasia.[J]. Blood Adv 2(20):2704\u20132712. https:\/\/doi.org\/10.1182\/bloodadvances.2018022723","journal-title":"Blood Adv"},{"issue":"8","key":"6315_CR27","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.21037\/jtd.2018.07.14","volume":"10","author":"S Moriyama","year":"2018","unstructured":"Moriyama S, Yano M, Haneda H et al (2018) Pure red cell aplasia associated with thymoma: A report of a Single-Center Experience.[J]. J Thorac Disease 10(8):5066\u20135072. https:\/\/doi.org\/10.21037\/jtd.2018.07.14","journal-title":"J Thorac Disease"},{"issue":"2","key":"6315_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12185-018-2446-y","volume":"108","author":"X Wu","year":"2018","unstructured":"Wu X, Wang S, Lu X et al (2018) Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell Aplasia: serial experience at a single Center.[J]. Int J Hematol 108(2):123\u2013129. https:\/\/doi.org\/10.1007\/s12185-018-2446-y","journal-title":"Int J Hematol"},{"issue":"41","key":"6315_CR29","doi-asserted-by":"publisher","first-page":"e17425","DOI":"10.1097\/MD.0000000000017425","volume":"98","author":"X Wu","year":"2019","unstructured":"Wu X, Yang Y, Lu X et al (2019) Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with Corticosteroids.[J]. Medicine 98(41):e17425. https:\/\/doi.org\/10.1097\/MD.0000000000017425","journal-title":"Medicine"},{"issue":"3","key":"6315_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00277-020-03926-6","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Lu X, Chen L et al (2020) Immunosuppressive therapy for Elderly-Acquired pure red cell Aplasia: cyclosporine A May be more Effective.[J]. Ann Hematol 99(3):443\u2013449. https:\/\/doi.org\/10.1007\/s00277-020-03926-6","journal-title":"Ann Hematol"},{"issue":"8","key":"6315_CR31","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00277-020-04154-8","volume":"99","author":"Z Long","year":"2020","unstructured":"Long Z, Li H, Du Y et al (2020) Gene mutation profile in patients with acquired pure red cell Aplasia.[J]. Ann Hematol 99(8):1749\u20131754. https:\/\/doi.org\/10.1007\/s00277-020-04154-8","journal-title":"Ann Hematol"},{"key":"6315_CR32","doi-asserted-by":"publisher","unstructured":"Liu X, Li R, Liu Z et al (2021) Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: Cyclophosphamide Responded Better Than Cyclosporine[J]. BLOOD, 138 MA-(63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) CL-Atlanta, GA PU-AMER SOC HEMATOLOGY PI-WASHINGTON PA-2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA). https:\/\/doi.org\/10.1182\/blood-2021-154248","DOI":"10.1182\/blood-2021-154248"},{"issue":"1","key":"6315_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/rheumatology\/keab363","volume":"61","author":"H Lobbes","year":"2021","unstructured":"Lobbes H, Mah\u00e9vas M, Alviset S et al (2021) Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the Literature.[J]. Rheumatology (Oxford) 61(1):355\u2013366. https:\/\/doi.org\/10.1093\/rheumatology\/keab363","journal-title":"Rheumatology (Oxford)"},{"key":"6315_CR34","doi-asserted-by":"publisher","first-page":"759914","DOI":"10.3389\/fmed.2021.759914","volume":"8","author":"C-C Yen","year":"2021","unstructured":"Yen C-C, Huang W-L, Li S-S et al (2021) Pure red cell aplasia and other haematological diseases associated with thymoma: A case series and systematic Review.[J]. Front Med 8:759914. https:\/\/doi.org\/10.3389\/fmed.2021.759914","journal-title":"Front Med"},{"issue":"6","key":"6315_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12185-022-03310-2","volume":"115","author":"F Kawakami","year":"2022","unstructured":"Kawakami F, Kawakami T, Yamane T et al (2022) T cell clonal expansion and STAT3 mutations: A characteristic feature of acquired chronic T cell-Mediated pure red cell Aplasia.[J]. Int J Hematol 115(6):816\u2013825. https:\/\/doi.org\/10.1007\/s12185-022-03310-2","journal-title":"Int J Hematol"},{"issue":"2","key":"6315_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41408-022-00632-6","volume":"12","author":"Y Salama","year":"2022","unstructured":"Salama Y, Zhao F, Oliveira JL et al (2022) Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).[J]. Blood Cancer J 12(2):30. https:\/\/doi.org\/10.1038\/s41408-022-00632-6","journal-title":"Blood Cancer J"},{"issue":"7","key":"6315_CR37","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00277-022-04847-2","volume":"101","author":"X Wu","year":"2022","unstructured":"Wu X, Cheng L, Liu X et al (2022) Clinical characteristics and outcomes of 100 adult patients with pure red cell Aplasia.[J]. Ann Hematol 101(7):1493\u20131498. https:\/\/doi.org\/10.1007\/s00277-022-04847-2","journal-title":"Ann Hematol"},{"issue":"1","key":"6315_CR38","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/s41598-023-33928-z","volume":"13","author":"S Park","year":"2023","unstructured":"Park S, Yun J, Choi SY et al (2023) Distinct mutational pattern of T-Cell large granular lymphocyte leukemia combined with pure red cell Aplasia: low mutational burden of STAT3.[J]. Sci Rep 13(1):7280. https:\/\/doi.org\/10.1038\/s41598-023-33928-z","journal-title":"Sci Rep"},{"key":"6315_CR39","doi-asserted-by":"publisher","unstructured":"Yang Y, Tang Z, Huang Y et al Sirolimus versus cyclosporine A in patients with primary acquired pure red cell Aplasia: A prospective cohort Study.[Z](2023\u201305). https:\/\/doi.org\/10.1038\/s41408-023-00845-3","DOI":"10.1038\/s41408-023-00845-3"},{"key":"6315_CR40","doi-asserted-by":"publisher","unstructured":"Yang L, Niu H, Zhang T, Cao Q, Liu M, Liu Y, Yan L, Qi W, Wang T, Liu C, Li L, Xing L, Wang H Shao Z F RA nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia. Ann Hemato[J] Ann Hematol [no date], 103(6): 1877\u20131885. https:\/\/doi.org\/10.1007\/s00277-024-05636-9","DOI":"10.1007\/s00277-024-05636-9"},{"key":"6315_CR41","doi-asserted-by":"publisher","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis YC JMethodological index for Non-Randomized studies (Minors): development and validation of a new Instrument[J]. ANZ J Surg [no date], 73(9): 712\u2013716. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"issue":"6","key":"6315_CR42","first-page":"1002","volume":"16","author":"DF Thompson","year":"1996","unstructured":"Thompson DF, Gales M, ADrug-Induced (1996) Pure Red Cell Aplasia [J] Pharmacotherapy 16(6):1002\u20131008","journal-title":"Pure Red Cell Aplasia [J] Pharmacotherapy"},{"issue":"4","key":"6315_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N (2008) Hirokawa macquired pure red cell Aplasia: updated review of Treatment.[J]. Br J Haematol 142(4):505\u2013514. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07216.x","journal-title":"Br J Haematol"},{"key":"6315_CR44","doi-asserted-by":"publisher","unstructured":"Kawano Y, Katayama Y, Okamura A et al Pure red cell aplasia with primary sclerosing Cholangitis.[Z](2008\u201312). https:\/\/doi.org\/10.1007\/s12185-008-0206-0","DOI":"10.1007\/s12185-008-0206-0"},{"issue":"12","key":"6315_CR45","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1182\/blood-2006-12-063495","volume":"109","author":"EE Solomou","year":"2007","unstructured":"Solomou EE, Gibellini F, Stewart B et al (2007) Perforin gene mutations in patients with acquired aplastic Anemia.[J]. Blood 109(12):5234\u20135237. https:\/\/doi.org\/10.1182\/blood-2006-12-063495","journal-title":"Blood"},{"issue":"20","key":"6315_CR46","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","volume":"366","author":"HLM Koskela","year":"2012","unstructured":"Koskela HLM, Eldfors S, Ellonen P et al (2012) Somatic STAT3 mutations in large granular lymphocytic Leukemia.[J]. N Engl J Med 366(20):1905\u20131913. https:\/\/doi.org\/10.1056\/NEJMoa1114885","journal-title":"N Engl J Med"},{"issue":"3","key":"6315_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cas.12341","volume":"105","author":"F Ishida","year":"2014","unstructured":"Ishida F, Matsuda K, Sekiguchi N et al (2014) STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte Leukemia.[J]. Cancer Sci 105(3):342\u2013346. https:\/\/doi.org\/10.1111\/cas.12341","journal-title":"Cancer Sci"},{"key":"6315_CR48","doi-asserted-by":"crossref","unstructured":"Qiu Z-Y, Fan L, Wang L et al (2013) The Clinical Significance of STAT3 Mutation, LDH and \u03922-MG in T-Cell Large Granular Lymphocytic Leukemia[J]. BLOOD, 122(55th Annual Meeting of the American-Society-of-Hematology CL-New Orleans, LA PU-Amer soc hematology PI-washington PA-2021 L ST NW, suite 900, washington, DC 20036 USA)","DOI":"10.1182\/blood.V122.21.3483.3483"},{"issue":"1","key":"6315_CR49","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41598-021-81890-5","volume":"11","author":"N Fujishima","year":"2021","unstructured":"Fujishima N, Kohmaru J, Koyota S et al (2021) Clonal hematopoiesis in adult pure red cell Aplasia.[J]. Sci Rep 11(1):2253. https:\/\/doi.org\/10.1038\/s41598-021-81890-5","journal-title":"Sci Rep"},{"issue":"7","key":"6315_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/abbs\/gmy052","volume":"50","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shi Y, Song L et al (2018) Identification of mutations in patients with acquired pure red cell Aplasia.[J]. Acta Biochim Biophys Sin 50(7):685\u2013692. https:\/\/doi.org\/10.1093\/abbs\/gmy052","journal-title":"Acta Biochim Biophys Sin"},{"key":"6315_CR51","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010587","author":"H Lobbes","year":"2023","unstructured":"Lobbes H, Lega J-C, Le Guenno G et al (2023) Treatment strategy for acquired pure red cell Aplasia: A systematic review and Meta-Analysis[J\/OL]. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2023010587","journal-title":"Blood Adv"},{"issue":"12","key":"6315_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3760\/cma.j.cn115356-20211107-00256","volume":"31","author":"Y Hu","year":"2022","unstructured":"Hu Y, Yan X (2022) Ru SSirolimus in treatment of elderly T\u2043cell large granular lymphocytic leukemia accompanied with pure red cell Aplasia: report of 1 case and review of literature[J\/OL]. J Leuk Lymphoma 31(12):747\u2013748. https:\/\/doi.org\/10.3760\/cma.j.cn115356-20211107-00256","journal-title":"J Leuk Lymphoma"},{"key":"6315_CR53","first-page":"451","volume":"99","author":"M Miano","year":"2014","unstructured":"Miano M, Calvillo M, Palmisani E et al (2014) Sirolimus as treatment of steroid dependent\/resistant autoimmune haemolytic anemia\/pure red cell anemia in Children[J\/OL]. Haematologica 99:451\u2013452","journal-title":"Haematologica"},{"issue":"10","key":"6315_CR54","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJM199603073341004","volume":"334","author":"N Casadevall","year":"1996","unstructured":"Casadevall N, Dupuy E, Molho-Sabatier P et al (1996) Autoantibodies against erythropoietin in a patient with pure Red-Cell Aplasia.[J]. N Engl J Med 334(10):630\u2013633. https:\/\/doi.org\/10.1056\/NEJM199603073341004","journal-title":"N Engl J Med"},{"issue":"1","key":"6315_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1182\/blood.V59.1.114.114","volume":"59","author":"EN Dessypris","year":"1982","unstructured":"Dessypris EN, Krantz SB, Roloff JS et al (1982) Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of Children.[J]. Blood 59(1):114\u2013123","journal-title":"Blood"},{"issue":"4","key":"6315_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/03009749509100884","volume":"24","author":"R Duchmann","year":"1995","unstructured":"Duchmann R, Schwarting A, Poralla T et al (1995) Thymoma and pure red cell aplasia in a patient with systemic lupus Erythematosus.[J]. Scand J Rheumatol 24(4):251\u2013254. https:\/\/doi.org\/10.3109\/03009749509100884","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"6315_CR57","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.13376","volume":"169","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Sawada K, Fujishima N et al (2015) Long-Term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: A final report of the nationwide cohort study in 2004\/2006 by the Japan PRCA collaborative study Group.[J]. Br J Haematol 169(6):879\u2013886. https:\/\/doi.org\/10.1111\/bjh.13376","journal-title":"Br J Haematol"},{"issue":"3","key":"6315_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg JF, Wrzeszczynska MH, Devgan G et al (1999) Stat3 as an Oncogene.[J]. Cell 98(3):295\u2013303. https:\/\/doi.org\/10.1016\/s0092-8674(00)81959-5","journal-title":"Cell"},{"key":"6315_CR59","unstructured":"Mangla AH HPure Red Cell Aplasia[M]"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06315-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06315-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06315-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:13:52Z","timestamp":1746414832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06315-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6315"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06315-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}